Qi WX, Li S, Li H, Chen J, et al. The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort. BMC Cancer 2024;24:1029.
PMID: 39164624